ABT logo

ABBOTT LABORATORIES

ABTNYSE
πŸ† #77 by market capEarnings Jan 28US Equity
$102.67β–Ό $0.43 (βˆ’0.42%)
πŸŒ™ After hours$103.80β–² 1.10%Regular close Β· extended-hours price shown
πŸ””
Track ABT
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.4%
7dβ–² 2.1%
14dβ–Ό 0.3%
30dβ–² 1.7%
ytdβ–Ό 18.0%
1yβ–Ό 18.9%
🏦Market Cap
$177.66B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
10.0%
Healthy
πŸ“ŠGross Margin
57.1%
Healthy
πŸ’΅FCF Margin
16.2%
Healthy
βš–οΈP/S Ratio
3.8x
Fair
Otter Score
72
Strong

Trading Snapshot

Day Range
$101.54 – $103.93
52-Week Range
$81.97 – $132.03
Volume (shares)
5,464,176
Avg Volume (shares)
β€”
Shares Outstanding
1.73B
Next Earnings
2027-01-28

Fundamentals Snapshot

Annual Revenue
$44.33B
Last Q Revenue
$13.01B
P/E Ratio
38.6
P/S Ratio
3.8x
EPS (TTM)
$2.70
Dividend Yield
2.35%
Dilution (1yr)
+0.1%
ABT logo

ABBOTT LABORATORIES

ABT
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$44.3Bβ–² +5.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
55.5%β–² +9.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$8.0Bβ–² +17.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$7.4Bβ–² +16.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.75Bβ–² +0.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$6.5Bβ–² +$1.1B YoY
StockOtter Β· stockotter.space

About ABBOTT LABORATORIES

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
72/100
Analyst data unavailable.

Latest News & Updates

FinboldΒ·11h ago

U.S. politician makes super suspicious Big Tech stock trades

Republican Rep. Pete Sessions of Texas has disclosed substantial stock sales involving major technology companies.

24/7 Wall StreetΒ·1d ago

Medtronic Has Raised Its Dividend for 49 Years. These 2 Rivals Have Even Longer Streaks

Medtronic's 49-year dividend streak sounds impressive until you meet the two medical device rivals that have been raising payouts even longer, and the differences in yield, valuation, and balance sheet strength could res

Zacks Investment ResearchΒ·1d ago

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) ana

Zacks Investment ResearchΒ·1d ago

Is Most-Watched Stock Abbott Laboratories (ABT) Worth Betting on Now?

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Seeking AlphaΒ·1d ago

Abbott: Demand Headwinds And Litigation Risks Priced-In - Spin-Off Tailwinds Ahead

FQ4'26 noise from EP/CGM demand headwinds has contributed to Abbott's lowered FY2026 guidance and range-bound stock price action afterwards. Nutrition spin-off may unlock MedTech/Diagnostic/Pharmaceutical's growth, impro

Defense WorldΒ·1d ago

Abbott Laboratories $ABT Shares Purchased by Evergreen Capital Management LLC

Evergreen Capital Management LLC boosted its stake in shares of Abbott Laboratories (NYSE: ABT) by 40.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange C